Hot Topic Webinars

Objective

To share pharmacoepidemiological learnings from own research.

Form

8 scheduled presentations per year (posted here on DSFE’s homepage). Each session lasts 45 minutes and covers one specific paper and one theoretical topic. The theoretical presentation will constitute no more than 10 minutes and cover an issue related to the paper but presented in its own right, e.g. surveillance bias, propensity score adjustment, or reverse causation. The presentation of the paper focuses on the methods applied and the analytical choices made during the project (and their underlying rationale). The aim is to give a pragmatic walkthrough to highlight the practical issues faced, more so than the overarching methodology or clinical area of interest. The paper presentation takes no more than 25 minutes, which leaves 10 minutes for questions from attendees.

How to participate

Access the meeting room here.

We recommend testing the setup prior to the meeting by accessing the above link and clicking “Go to test site”.

All mics of participants will be muted centrally. In case of questions (during the last 10 minutes), please mark “raise your hand” and your mic will be centrally unmuted.

When

End of each month at 9.00 (only September-November and January-May)

DatePresenterPaperTheoretical topicLink to previous presentations
Sep 28Lina Steinrud MørchAssociation of Hormonal Contraception With Suicide Attempts and SuicidesSurveillance and healthy user biasRecording
Oct 26Anton PottegårdUse of antipsychotics and risk of breast cancer: a Danish nationwide case-control study.Exposure ascertainment in cancer studiesRecording
Jan 30Ellen LøkkegaardUsing prescription registries to define continuous drug use: how to fill gaps between prescriptions.
Conditioning on future exposure to define study cohorts can induce bias: the case of low-dose acetylsalicylic acid and risk of major bleeding.
Conditioning on the future in pharmacoepidemiologyRecording

Feb 28Marie HargreaveMaternal use of fertility drugs and risk of cancer in children—A nationwide population‐based cohort study in DenmarkSeperating effects of the treatment from the underlying diseaseRecording

Mar 27Morten SchmidtDiclofenac use and cardiovascular risks: series of nationwide
cohort studies
Diclofenac and cardiovascular risksRecording

Apr 25Kasper AdelborgUse of histamine H2 receptor antagonists and outcomes in patients with heart failure: a nationwide population-based cohort studyNew-user active comparator cohort studies
MayTBATBATBA
Scroll to top